Anders Hove

Develops and commercializes drugs

Operates as biotechnology company which develops therapies

Manufactures and markets health care and nutritional products

Manufactures pharmaceuticals

Develops medicines which includes protein antagonists

Functions as a College/University

Functions as a College/University

The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest.

Functions as a College/University

Operates as a bio pharmaceutical company

Provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections

Develops blood glucose monitoring system for diabetic patients

Acts as Venture Capital Fund

Develops genetic therapies for heart failure and cardiovascular diseases

VHCP Management’s funds focus on long-term investment opportunities in small-cap public companies and late-stage private companies across all sectors in the healthcare and life sciences industry, with a current emphasis on biopharmaceuticals.

Bellevue Asset Management takes a comprehensive approach using probabilistic financial planning. To minimize expense for their clients, they utilize Index Exchange Traded Funds (ETFs), individual stocks, and no-load funds for equity investing. For fixed income, the firm invests in a variety of instruments from individual corporate and municipal bonds funds to preferred stock to no-load bond funds.

Provides development services for a variety of dosage forms

Majalin is an active manager that invests in both private and public healthcare companies located in the US. The firm targets companies operating in fields across the healthcare sector such as therapeutics, devices, diagnostics and services and innovative life science companies. The investment size is a minimum of USD 5 million in venture capital deals and up to USD 75 million or more in growth equity investments.

Manufactures therapies for chronic inflammatory diseases

Functions as a venture capital fund

Acorn Bioventures invests in small-cap public and private companies located in the United States. The firm target companies operating in the fields of health & biotechnology sectors. It provides financing for seed, cross-over financings, IPOs, registered direct offerings and PIPEs transactions.

Provides investment advice